• news.cision.com/
  • Navamedic ASA/
  • Vitaflo Scandinavia has signed an out-licensing agreement for the distribution and sale of SPC-Flakes and Salovum in Italy

Vitaflo Scandinavia has signed an out-licensing agreement for the distribution and sale of SPC-Flakes and Salovum in Italy

Report this content
(Gothenburg, March 10, 2009) Vitaflo Scandinavia AB, a subsidiary of Navamedic ASA, has signed an exclusive out-licensing agreement with Medifood, a company in the Vecchi & C. Piam group, for the distribution and sale of SPC-Flakes and Salovum in ITALY.



"I am very pleased that we have signed this agreement between Medifood and Vitaflo Scandinavia. I am sure that both Salovum and SPC-Flakes will give us great opportunities. With the company's history and competence, we believe that Medifood and Vitaflo Scandinavia have a great opportunity to develop a very successful cooperation", says Dr. Piero Pescetto, managing director for Medifood



About AF, SPC-Flakes and Salovum.

The products are classified as food for special medical purpose. Swedish scientists were the first to discover the Antisecretory protein, Factor AF, an endogenous protein found in all living species, including the human body, regulating the body's secretory and Ion balance. Scientists have found and documented, in a long row of Clinical studies, that people suffering from IBD, Mb Meniere and severe diarrhoea, have low amounts of protein AF. Both Swedish and international studies have shown that SPC-Flakes and Salovum can be used effectively of regulating the level of protein AF to therapeutic levels.




- Both SPC and Salovum have shown effect in a number of clinical studies in Sweden and abroad, and are subject to patents all over the world. The patents last until 2014, 2016 respectively, and new patent applications were filed in 2006.




SPC-Flakes is used in the treatment of inflammatory bowel disease (IBD) and Mb Ménières disease causing dizziness. Salovum is effective in the acute treatment of inflammatory and secretory conditions.



SPC-Flakes and Salovum have been sold in Sweden for some years. First by Lantmännen AF - Faktor AB, then by Vitaflo Scandinavia who has had the word wide product rights since July 2008. Vitaflo Scandinavia will market and sell the products in its home-market and search for partners elsewhere. With this agreement and the agreement with Vitaflo International, Vitaflo Scandinavia has signed sales and distribution agreements for 12 countries outside its home-market.



The agreement with Medifood is valid for a period of four years.




About Medifood:
Vecchi & C. Piam is a pharmaceutical firm established 1915 in Genoa - Italy. Vecci & C.Piam has interest in pneumology, neurology, geriatric, cardiovascular, antibiotics and medical nutrition branches. The company has 7 area managers and about 100 employees spread over the whole Italy



Medifood (with 2 area managers and 25 employees in Italy) specializes in inborn metabolic diseases, such as PKU and special protein free food. Furthermore it works in a paediatrics area with some food supplements.




About Vitaflo:
Vitaflo Scandinavia AB, a fully owned subsidiary of Navamedic ASA, is one of the fastest growing specialty pharmaceutical sales and marketing companies in the Nordic area working in 10 therapy areas.



Vitaflo Scandinavia promotes branded and generic prescription medicines; food for specific medical needs as well as OTC products. Vitaflo Scandinavia has its own marketing presence in Denmark, Finland, Iceland, Sweden, Norway and Holland and will have its products marketed through distributors in another 12 territories during 2009.






For further information, please contact:
Roland Sandström, Executive Chairman, Vitaflo Scandinavia AB
E-mail: roland.sandstrom@vitaflo.net
Office: +46 31 335 11 90



Tina Sandström, Managing Director, Vitaflo Scandinavia AB
E-mail: tina.sandstrom@vitaflo.net
Office: +45 48 22 18 38



Dr. Piero Pescetto, Managing Director, Medifood
E-mail:mbenvenuto@piamfarmaceutici.com



Office: 10 518 62 209



Bernt-Olav Røttingsnes, CEO/IRO Navamedic ASA
E-mail: bor@navamedic.com
Office: +47 67 11 25 44
Mobile: +47 91 34 70 21








Subscribe